Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026)

Ovid Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.04 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 499.91% year-over-year to 0.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04 (up 499.91% YoY) and the FY2025 annual result came in at 0.06, up 1144.87% from the prior year.
• Asset Utilization Ratio was 0.04 for Q1 2026 at Ovid Therapeutics, down from 0.07 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2025 and bottomed at 0.0 in Q1 2023.
• A 5-year average of 0.02 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 99.19% — and 2025, when it surged 1738.0%.
• Ovid Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then sank by 68.95% to 0.0 in 2023, then surged by 99.41% to 0.01 in 2024, then soared by 1062.2% to 0.07 in 2025, then slumped by 43.98% to 0.04 in 2026.
• Business Quant data shows OVID's Asset Utilization Ratio at 0.04 in Q1 2026, 0.07 in Q4 2025, and 0.09 in Q3 2025.